Loading...
Products:Tags & Cell Markers >> Subcellular Markers >> Organelles >> Mitochondria
MSCatalog No. MSF42
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Frataxin protein
See all Frataxin products (3) ...
Recombinant full length Human Frataxin (amino acids 56-210); 155 amino acids, MWt 17.3kDa. (UniProt ID = Q16595).
Q16595
17.300kDa
155 amino acids
1.16.3.1
Lyophilised:
Ships at 4°C. Store lyophilized powder at 4°C. Reconstitute with 0.2 mL of H2O to a final concentration of 60ng/mL. Reconstituted solution should be stored at -80°C.
Concentration: 0.00006 mg/mL after reconstitution with 0.2 mL H2O
Shipped at 4°C. Store lyophilized powder at 4°C. After reconstitution store at -80ºC. Avoid freeze / thaw cycles.
Constituent: 1% BSA
Concentration information loading...
Metabolism >> Types of disease >> Cancer
Metabolism >> Pathways and Processes >> Mitochondrial Metabolism >> Mitochondrial markers
Signal Transduction >> Metabolism >> Mitochondrial
Tags & Cell Markers >> Subcellular Markers >> Organelles >> Mitochondria
Sandwich ELISA - Frataxin protein (ab110353)
(enlarge)
Our Abpromise guarantee covers the use of ab110353 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
sELISA: Use a concentration of 0.0002 - 0.0125 µg/ml.
This peptide can be used with studies using ab110173.
Promotes the biosynthesis of heme and assembly and repair of iron-sulfur clusters by delivering Fe(2+) to proteins involved in these pathways. May play a role in the protection against iron-catalyzed oxidative stress through its ability to catalyze the oxidation of Fe(2+) to Fe(3+); the oligomeric form but not the monomeric form has in vitro ferroxidase activity. May be able to store large amounts of iron in the form of a ferrihydrite mineral by oligomerization; however, the physiological relevance is unsure as reports are conflicting and the function has only been shown using heterologous overexpression systems. Modulates the RNA-binding activity of ACO1.
Expressed in the heart, peripheral blood lymphocytes and dermal fibroblasts.
Defects in FXN are the cause of Friedreich ataxia (FRDA) [MIM:229300]. FRDA is an autosomal recessive, progressive degenerative disease characterized by neurodegeneration and cardiomyopathy it is the most common inherited ataxia. The disorder is usually manifest before adolescence and is generally characterized by incoordination of limb movements, dysarthria, nystagmus, diminished or absent tendon reflexes, Babinski sign, impairment of position and vibratory senses, scoliosis, pes cavus, and hammer toe. In most patients, FRDA is due to GAA triplet repeat expansions in the first intron of the frataxin gene. But in some cases the disease is due to mutations in the coding region.
Belongs to the frataxin family.
Processed in two steps by mitochondrial processing peptidase (MPP). MPP first cleaves the precursor to intermediate form and subsequently converts the intermediate to yield frataxin mature form (frataxin(81-210)) which is the predominant form. The additional forms, frataxin(56-210) and frataxin(78-210), seem to be produced when the normal maturation process is impaired; their physiological relevance is unsure.
Cytoplasm. Mitochondrion. PubMed:18725397 reports localization exclusively in mitochondria.
Target information above from: UniProt accessionQ16595
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
This product has been referenced in:
See all 2 publications for this product
Publishing research using ab110353? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
